EC Number   |
Activating Compound |
Reference |
|---|
    1.1.1.49 | 1-(1-(4-chlorophenyl)-2-nitroethyl)-1H-indole |
- |
761410 |
| 1.1.1.49 | 1-(1-(furan-2-yl)-2-nitroethyl)-1H-indole |
- |
761410 |
| 1.1.1.49 | 1-(2-nitro-1-phenylethyl)-1H-indole |
- |
761410 |
| 1.1.1.49 | 5-(3alpha,12alpha-dihydroxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide |
weak activation |
688050 |
| 1.1.1.49 | 5-(3alpha,acetoxy-5-beta-cholanamido)-1,3,4-thiadiazole-2-sulfonamide |
activates |
688050 |
| 1.1.1.49 | 6-aminohexanoic acid |
marginally increases the refolding yield in the presence of Arg, and it is unable to replace Arg in promoting a high refolding yield |
696962 |
| 1.1.1.49 | acetazolamide |
activates |
688050 |
| 1.1.1.49 | anhydrotetracyclin |
induces expression of mature G6PDH1 |
697951 |
| 1.1.1.49 | artesunate |
induces a 25fold increase in glucose-6-phosphate dehydrogenase activity while there is no significant reduction in the red blood cell count. Critical role for glucose-6-phosphate dehydrogenase in the prevention of oxidative stress and lysis of red blood cells in artesunate-treated rats |
695426 |
| 1.1.1.49 | ATP |
isoform Zwf-2 is active in the presence of 3m MATP, and then only with NADP+ as a coenzyme |
739909 |
